These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Tyranny of algorithms in the treatment of patients with hepatitis C. Rubin RA Hepatology; 2003 Dec; 38(6):1593-4; author reply 1594-5. PubMed ID: 14647072 [No Abstract] [Full Text] [Related]
29. Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage. Moreno A; Quereda C; Fortún J; Bárcena R; Pérez-Elías MJ; Casado JL; Rodríguez-Sagrado MA; Mateos ML; Blesa C; Moreno S AIDS; 2010 May; 24(8):1231-3. PubMed ID: 20421744 [No Abstract] [Full Text] [Related]
30. Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection. Henry MJ N Engl J Med; 2005 Sep; 353(11):1182-3; author reply 1182-3. PubMed ID: 16167381 [No Abstract] [Full Text] [Related]
31. The "pegylated" story continues--perhaps because both ends (α2a and α2b) are true? Reiberger T; Peck-Radosavljevic M J Hepatol; 2012 Jul; 57(1):226-8; author reply 229. PubMed ID: 22390901 [No Abstract] [Full Text] [Related]
32. Amantadine for treatment of hepatitis C: time to say "enough is enough"? Piccolo P Dig Liver Dis; 2010 Jul; 42(7):468-9. PubMed ID: 20488769 [No Abstract] [Full Text] [Related]
33. Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons. Husa P; Husova L Bratisl Lek Listy; 2001; 102(5):248-52. PubMed ID: 11725377 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of elderly patients with chronic hepatitis C]. Ikeda F; Yamamoto K; Iwasaki Y Nihon Rinsho; 2011 May; 69 Suppl 4():221-6. PubMed ID: 22096923 [No Abstract] [Full Text] [Related]
36. [Antiviral therapy for chronic viral hepatitis B and C]. Iino S Nihon Rinsho; 2003 Feb; 61 Suppl 2():787-91. PubMed ID: 12722317 [No Abstract] [Full Text] [Related]
37. Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 cases. Buti M; Valdés A; Sánchez-Avila F; Esteban R; Lurie Y Hepatology; 2003 May; 37(5):1226-7. PubMed ID: 12717407 [No Abstract] [Full Text] [Related]
38. [Effectiveness of long-acting interferon (peginterferon)]. Kondo Y; Tateishi R; Yoshida H; Omata M Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):515-8. PubMed ID: 15359853 [No Abstract] [Full Text] [Related]
39. [Pegylated interferon plus ribavirin in chronic hepatitis C. More than half of patients show a lasting response]. Zeuzem S MMW Fortschr Med; 2002 Feb; 144(8):30-4. PubMed ID: 11910820 [TBL] [Abstract][Full Text] [Related]
40. Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection. Borg BB; Hoofnagle JH N Engl J Med; 2005 Sep; 353(11):1182-3; author reply 1182-3. PubMed ID: 16162894 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]